Production (Stage)
Orchestra BioMed Holdings, Inc.
OBIO
$2.72
-$0.01-0.37%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.89M | 2.64M | 2.65M | 2.08M | 2.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.89M | 2.64M | 2.65M | 2.08M | 2.22M |
| Cost of Revenue | 214.00K | 204.00K | 193.00K | 166.00K | 176.00K |
| Gross Profit | 2.67M | 2.43M | 2.45M | 1.91M | 2.04M |
| SG&A Expenses | 24.30M | 23.93M | 22.22M | 22.89M | 21.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 71.69M | 66.94M | 62.75M | 60.37M | 56.60M |
| Operating Income | -68.80M | -64.30M | -60.11M | -58.29M | -54.38M |
| Income Before Tax | -66.32M | -61.02M | -57.69M | -55.58M | -51.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -66.32 | -61.02 | -57.69 | -55.58 | -51.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -66.32M | -61.02M | -57.69M | -55.58M | -51.64M |
| EBIT | -68.80M | -64.30M | -60.11M | -58.29M | -54.38M |
| EBITDA | -68.48M | -63.99M | -59.81M | -58.00M | -54.09M |
| EPS Basic | -1.77 | -1.66 | -1.60 | -1.57 | -1.47 |
| Normalized Basic EPS | -1.11 | -1.03 | -0.97 | -0.96 | -0.89 |
| EPS Diluted | -1.77 | -1.66 | -1.60 | -1.57 | -1.47 |
| Normalized Diluted EPS | -1.11 | -1.03 | -0.97 | -0.96 | -0.89 |
| Average Basic Shares Outstanding | 149.72M | 147.26M | 144.34M | 141.96M | 140.78M |
| Average Diluted Shares Outstanding | 149.72M | 147.26M | 144.34M | 141.96M | 140.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |